Robinhood Ventures Fund II Prices IPO At $25/share
Robinhood Ventures Fund II (RVII) priced its IPO of 8 million common shares at $25 each, targeting total proceeds of up to $225.5 million. Shares are expected to start trading on the NYSE on Aug. 13 under ticker RVII, with the offering closing Aug. 14. Underwriters can buy 1.2 million more shares at $25 for up to $255.5 million total. Goldman Sachs is lead bookrunner.
How this was made
The 30-second read
Why it matters
For traders, the actionable elements are the $25 offer price, the expected NYSE start date (Aug 13), and the potential upsizing to $255.5 million if the underwriters exercise the option.
Market read
This is a primary IPO pricing and listing-timing update that can drive first-day order flow and volatility for RVII.
What to watch
The article does not provide valuation, investor base, or use of proceeds details, which are key for assessing longer-term risk beyond first-day trading.
Background
Robinhood Ventures Fund II (RVII) is conducting an IPO with a defined offer size and an underwriter option (greenshoe) that can increase total shares and proceeds.
Ticker impact
Robinhood Ventures Fund II priced an IPO of 8 million shares at $25, with NYSE trading starting Aug 13 under symbol RVII.
Near-term volatility likely around first-day trading as the market digests the $25 offer price and potential greenshoe size.
The article discloses the offer price, share count, expected start date, and underwriter option size, which are primary inputs for IPO demand and opening pricing.
Market effects
Limited direct read-through, but adds a new listed vehicle in the venture/development fund space.
Primarily US-focused via NYSE listing and IPO mechanics.
Low, as the disclosure is company-specific and not tied to global macro or cross-border regulation.
Counterpoint
IPO pricing at a single fixed level may not translate into sustained post-listing performance if demand was only sufficient to clear the offer.
Key entities
- companyRobinhood Ventures Fund II
Development company that priced its IPO at $25 per share and will begin trading on the NYSE under symbol RVII.
- underwriterGoldman Sachs & Co. LLC
Lead bookrunner for the IPO.
